AGILENT TECHNOLOGIES, INC.A

時価総額

$429.6億

PER

分析機器・診断・ゲノミクス分野の大手。自動化病理装置やフローサイトメトリー、NGS用試薬とmRNA向けCDMOサービスを展開。2024年9月にCDMO企業を9.15億ドルで買収。北米・欧州・アジア中心に製造拠点を展開。

	2011年 10月31日	2012年 10月31日	2013年 10月31日	2014年 10月31日	2015年 10月31日	2016年 10月31日	2017年 10月31日	2018年 10月31日	2019年 10月31日	2020年 10月31日	2021年 10月31日	2022年 10月31日	2023年 10月31日	2024年 10月31日
Net Income	1,012	1,153	724	504	401	462	684	316	1,071	719	1,210	1,254	1,240	1,289
Depreciation and amortization	253	301	372	384	253	246	212	210	238	308	321	317	271	257
Share-based compensation	72	74	85	96	54	58	60	70	72	83	110	125	111	129
Deferred taxes expense (benefit)	38	-158	31	-132	70	3	102	-16	-255	29	14	8	-56	-64
Inventory Write-down	30	30	48	79	30	20	24	26	19	28	29	24	40	45
Net gain (loss) on equity securities	-	-	-	-	-	-	-	-	-	-	98	-67	-41	6
Asset impairment charges	-	-	-	-	-	-	-	21	-	99	2	-	277	19
Change in fair value of contingent consideration	-	-	-	-	-	-	-	-	-	-	-21	-25	1	-
Loss on extinguishment of debt	-	-	-	-	-	-	-	-	-9	-	-17	-9	-	-
Net gain on Divestiture of Business	-	-	-	-	-	-	-	-	-	-	-	-	43	-
Other non-cash expense, net	-9	-5	-3	-10	-13	-17	-7	-9	-6	-8	-3	-11	-6	1
Accounts receivable, net	-11	-19	-14	119	24	33	81	65	106	107	128	321	-132	-7
Inventory	208	52	100	99	24	7	61	83	36	68	136	248	33	-34
Accounts payable	-35	-31	-27	50	-26	-15	2	40	29	2	64	121	-171	103
Employee compensation and benefits	24	-54	16	9	8	15	38	31	23	29	112	-22	-91	-12
Other assets and liabilities	16	58	17	60	262	-10	98	4	43	181	14	8	-47	49
Net cash provided by operating activities	1,260	1,228	1,152	711	491	793	889	1,087	1,021	921	1,485	1,312	1,772	1,751
Payments to acquire property, plant and equipment	188	194	195	205	98	139	176	177	155	119	188	291	298	378
Proceeds from the sale of equity securities	-	-	-	-	-	-	-	-	-	-	12	22	5	-
Payments to acquire equity securities	-	-	-	-	-	-	-	-	-	-	22	13	8	5
Proceeds from convertible note	-	-	-	-	-	-	-	-	-	-	-	-	4	-
Payment in exchange for convertible note	-	-	-	-	2	1	1	2	3	9	5	4	12	13
Proceeds from Divestiture of Businesses	-	-	-	-	-	-	-	-	-	-	-	-	50	-
Acquisitions of businesses and intangible assets, net of cash acquired	98	2,257	21	13	74	261	128	516	1,408	-	546	52	51	862
Net cash used in investing activities	1,294	-2,372	-248	-230	-400	-238	-305	-704	-1,590	-147	-749	-338	-310	-1,258
Proceeds from the issuance of common stock under employee stock plans	304	100	161	188	58	62	66	56	54	60	55	58	67	77
Payment of taxes related to net share settlement of equity awards	-	-	-	-	-	6	14	30	16	37	76	67	54	30
Payments for repurchase of common stock	497	172	900	200	267	434	194	422	723	469	788	1,139	575	1,150
Payment of excise taxes related to repurchases of common stock	-	-	-	-	-	-	-	-	-	-	-	-	-	3
Payment of dividends	-	104	156	176	133	150	170	191	206	222	236	250	265	274
Proceeds from Issuance of Long-Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	1,197
Repayments of Long-Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	600
Payments of debt issuance costs	-	3	5	9	-	2	-	-	4	4	7	-	-	9
Proceeds from (Repayments of) Short-Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-35	40
Payment for Contingent Consideration	-	-	-	-	-	-	-	-	-	-	-	-	68	-
Net cash used in financing activities	-1,693	-31	-554	-97	-1,068	-268	-202	-797	-299	-717	-696	-1,372	-930	-752
Effect of exchange rate movements	-	-	-	-	-	-	-	-	-	-	-	-36	5	-2
Net increase (decrease) in cash, cash equivalents and restricted cash	-	-	-	-	-	-	-	-	-866	59	43	-434	537	-261
Income Taxes Paid, Net	-	-	-	-	-	-	-	-	-	-	211	279	199	314
Interest payments, net of capitalized interest	-	-	-	-	-	73	82	80	80	71	76	85	89	80
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	4	9